Y CombinatorKima VenturesMotier VenturesNorth South VenturesCircle & CoGeneral Catalyst
Description
Lucis, a French startup focused on preventive health testing, has raised $8.5 million in a seed round led by General Catalyst. The funding will support Lucis's mission to improve health monitoring across Europe. The platform helps users track over 180 biomarkers for chronic disease prevention. With certified medical reviews and AI integration, Lucis enhances consumer health tracking with clinical oversight.
Who to call at Lucis, and when
A new round usually means Lucis is about to hire and buy. The teams that reach out first get the meeting.
An alert the day Lucis raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at Lucis, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Lucis. With Fundz connected, it knows.
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
Company Information
Company
Lucis
Location
Artannes-sur-Indre, Centre-Val de Loire, France
About
Lucis is a French startup focused on expanding access to preventive health testing. It offers a platform that translates blood test results into indicators tracked every six to 12 months, covering over 180 biomarkers. The company's mission is to empower individuals to take ownership of their health by providing clear insights before symptoms appear. Lucis does not replace medical consultation or diagnosis but supports health monitoring with AI-driven insights.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Lucis raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Artannes-sur-IndreBiotechnologyHealth CareArtificial Intelligence